RE: Effects of adjuvant chemotherapy on recurrence, survival and quality of life in stage II colon cancer patients: a 24-month follow-up

Supportive Care in Cancer

Volumn 24, Issue 10, 2016, Pages 4079-4080

  van Erning, F N ^a,b   Vissers, P A J ^a   Punt, C J A ^c   Lemmens, V E P P ^a,b  

^a Netherlands Comprehensive Cancer Organisation ^*  (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; COLON CANCER; DRUG EFFECT; FOLLOW UP; HUMAN; LETTER; MORTALITY RATE; PRIORITY JOURNAL; QUALITY OF LIFE; RECURRENCE RISK; ADJUVANT CHEMOTHERAPY; CANCER STAGING; COLON TUMOR; DISEASE FREE SURVIVAL; TUMOR RECURRENCE;

ANTINEOPLASTIC AGENT; FLUOROURACIL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; DISEASE-FREE SURVIVAL; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; QUALITY OF LIFE;

EID: 84966712922     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-016-3267-2     Document Type: Letter

References (6)

1. Lewis C, Xun P, He K (2016) Effects of adjuvant chemotherapy on recurrence, survival, and quality of life in stage II colon cancer patients: a 24-month follow-up. Support Care Cancer: Off J Multinatl Assoc Support Care Cancer 24(4):1463–1471. doi:10.1007/s00520-015-2931-2
2. Benson AB 3rd, Schrag D, Somerfield MR, Cohen AM, Figueredo AT, Flynn PJ, Krzyzanowska MK, Maroun J, McAllister P, Van Cutsem E, Brouwers M, Charette M, Haller DG (2004) American society of clinical oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol 22(16):3408–3419. doi:10.1200/JCO.2004.05.063
3. Verhoeff SR, van Erning FN, Lemmens VE, de Wilt JH, Pruijt JF (2016) Adjuvant chemotherapy is not associated with improved survival for all high risk factors in stage II colon cancer. Int J Cancer. doi:10.1002/ijc.30053
4. Morris M, Platell C, de Boer B, McCaul K, Iacopetta B (2006) Population-based study of prognostic factors in stage II colonic cancer. Br J Surg 93(7):866–871. doi:10.1002/bjs.5345
5. Lindskog EB, Gunnarsdottir KA, Derwinger K, Wettergren Y, Glimelius B, Kodeda K (2014) A population-based cohort study on adherence to practice guidelines for adjuvant chemotherapy in colorectal cancer. BMC Cancer 14:948. doi:10.1186/1471-2407-14-948
6. Andersen PK, Geskus RB, de Witte T, Putter H (2012) Competing risks in epidemiology: possibilities and pitfalls. Int J Epidemiol 41(3):861–870. doi:10.1093/ije/dyr213